Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02928458
Other study ID # 1609-39
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date September 1, 2015
Est. completion date September 13, 2017

Study information

Verified date December 2018
Source The Guthrie Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research study is for patients with adhesive small bowel obstruction (ASBO). ASBO is a condition in which the small intestine gets blocked due to scars called adhesions. To see the blockage, a contrast agent is given and an x-ray is taken of the belly (abdomen). MD Gastroview and omnipaque are two contrast agents that may be given as part of your normal care for ASBO. This study hopes to see if one is better than the other.


Description:

Small bowel obstruction is a common general surgical diagnosis providing a significant proportion (16%) of the emergency general surgery admissions. Unfortunately, there is a paucity of clear, well defined management protocols for this very common problem which results in a wide array of management techniques used by the general surgeon. It has already been shown that CT scan with IV contrast is the most accurate method of identifying strangulated bowel, a diagnosis that requires urgent surgical intervention(4). There is no variability in this aspect of the treatment arm for ASBO, rather the variability is found in the medical management of ASBO. Nasogastric tube (NGT) decompression is a universal component of non-operative management but the duration of NGT therapy and the definition of failed medical management requiring surgery lack a clear consensus. It is this aspect of the management of ASBO that I am hoping to better define. Water soluble contrast (MD-Gastroview) has been shown to be both diagnostic and therapeutic in the management of ASBO decreasing length of stay in this patient population. Not only does it expedite the resolution of ASBO, but is also yields objective evidence whether or not ASBO will resolve with medical management alone, therefore decreasing delay in the inevitable surgical intervention.

The hypothesis of this study is that the implementation of an evidence based adhesive small bowel obstruction protocol can reduce length of stay and reduce the financial burden on the health care system regarding this common general surgical problem. A second hypothesis is that MD-Gastroview and omnipaque will have similar properties regarding their diagnostic and therapeutic impact on ASBO.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date September 13, 2017
Est. primary completion date September 13, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Principle diagnosis of adhesive small bowel obstruction

Exclusion Criteria:

- Evidence of strangulation on initial CT scan leading to emergent operation

- Any known allergy to either contrast agent

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Omnipaque

MD-Gastroview


Locations

Country Name City State
United States The Guthrie Clinic Sayre Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
The Guthrie Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compare average length of stay for patients admitted with ASBO prior to and after implementation of this protocol. Three years
Secondary Compare statistically significant results relating to differences in the diagnostic and therapeutic effects of MD-Gastroview and omnipaque. Three years
See also
  Status Clinical Trial Phase
Completed NCT00332696 - Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis Phase 2
Completed NCT00216372 - Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis Phase 3
Completed NCT00758186 - Randomized Trial of Colonic Stents as a Bridge to Surgery Phase 3
Completed NCT02275338 - Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction Phase 2
Completed NCT03997721 - Pathophysiology of Perioperative Fluid Management in Emergency Laparotomy
Recruiting NCT01669044 - Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients N/A
Completed NCT01596764 - Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time. Phase 1
Completed NCT04020939 - The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery. N/A
Active, not recruiting NCT05229822 - Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction
Recruiting NCT06072976 - The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies N/A
Completed NCT01899885 - Acute High-risk Abdominal Surgery Study - an Optimized Perioperative Course N/A
Completed NCT00130715 - Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery N/A
Not yet recruiting NCT01125280 - Prospective Multicenter Validation of a Severity Score of Strangulated Small Bowel Occlusion N/A
Recruiting NCT06245577 - Biological Mesh Versus Synthetic Mesh in Interdisciplinary RRP With SCP N/A
Terminated NCT02365584 - Quality of Life in Patients With Inoperable Malignant Bowel Obstruction Phase 2
Completed NCT01596777 - Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects Phase 1
Not yet recruiting NCT04213976 - Ostomy in Continuity or Conventional Ileostomy: a Retrospective Multicentric Analysis
Completed NCT03663023 - Band Adhesions in Relation to Previous Abdominal Surgery
Active, not recruiting NCT03773237 - Intralipid Versus SMOFlipid in HPN Patients N/A
Recruiting NCT04403425 - Tissue Perfusion During Emergency Laparotomy